Cortisone Shots: Rising Prevalence of Chronic Diseases Such as Rheumatoid Arthritis And Lifestyle Changes Drives The Growth of The Global Market

Pune, India, 2022 /MRFR Press Release/- Market Research Future has a half cooked research report on the global Cortisone shots market. 

Market Highlights

Cortisone shots are used of the treatment of a spectrum of diseases. In dermatology, these shot are administered for skin conditions such as shingles, whereas in orthopedic they are used to treat joint pain and in the treatment of diseases such as osteoarthritis, and tendinitis. Medical practitioners also administer cortisone shots in the gluteus muscle to treat an allergic reaction.

Rising prevalence of chronic diseases such as rheumatoid arthritis, osteoarthritis, tendinitis and other diseases, extensive demand for the treatment of severe sport injuries and increasing number of sport medicine centers stimulate the growth of the market. Presence of key players also boost the growth of the market. The growth of the market is restricted due to the side effects of cortisone shots such as joint infection, and nerve damage.

The Cortisone Shots Market is projected to reach USD 6,328.3 Million by 2030 at 7.2% CAGR during the forecast period 2022-2030.

Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Cortisone shots market research report–Global forecast till 2030.”

Major Players in the Market:

Some of the key players in the global market are Merck & Co., Inc. (U.S.), Pfizer (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG (Germany), GlaxoSmithKline (U.S.), Pharmascience Inc. (U.S.), Farmabios SPA (Italy), AdvaCare Pharma (U.S.), and others.

Regional Analysis

In the Americas, rising prevalence of various types of allergies, arthritis, tendinitis, and others, and rising demand for corticosteroid injection in the U.S. are key drivers for the growth of the market. According to the Center for Disease Control and Prevention, from 2013- 2015, an estimated 54.4 million U.S. adults annually were diagnosed with rheumatoid arthritis, gout, lupus, or fibromyalgia.  They also estimated that nearly 78 million (26%) U.S. adults, aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040.

Europe is the second largest market for septic arthritis owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising prevalence of diabetes and obesity, which act as risk factors for the growth of the market. China, and India are the leading countries with increasing prevalence of diabetes.

The Middle East & Africa also show a steady rise in the market owing to high prevalence of chronic diseases, and increasing healthcare expenditure also influences the market growth in the Middle East & African countries.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Cortisone Shots Market Research Report

Segmentation

The global cortisone shots market is segmented on the basis of type, indication, and end user.

On the basis of type, market is segmented into articular or joint injections, epidural steroid injection, trigger point" injection, and others.

On the basis of indication, the market is segmented into rheumatoid arthritis, psoriatic arthritis, bursitis, allergic reaction, skin conditions, and others.

On the basis of end user, the market is segmented into hospitals, clinics, sport medicine centers, pharmaceutical companies, and others.